Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : GUMM - Eliminate the Common Cold -- Ignore unavailable to you. Want to Upgrade?

To: Hank who wrote (2308)	2/24/2000 1:52:00 PM
From: out_of_the_loop	Read Replies (1) \| Respond to of 5582

Hank, you should know that the 10-14 days was presented as an average. I am not sure of your point in arguing a single person's indiosyncratic average URTI duration.

To: Hank who wrote (2308)	2/24/2000 9:50:00 PM
From: Carl R.	Read Replies (2) \| Respond to of 5582

Just curious Hank, but am I a "stooge"? I am just a casual observer that has a small position in the stock. I don't necessarily recommend the stock, but I do recommend the product, and believe it works. As for the question of whether this is a P&D, there are plenty of P&D's out there, but this company doesn't resemble one, at least in my opinion. They have a real product, and one that I believe works. They are really trying to sell the product. They do a relatively small number of press releases compared to P&D scams. The only reason that I don't necessarily recommend the stock is that the company has some substantial risks, and those are: 1. Consumers will ultimately decide that the product is too unpleasant to use. 2. A larger competitor will end-run their patent and come out with a similar product, but have more money to promote the product. Note that neither of these risks involves them being a P&D. Carl